tiprankstipranks
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market

Revelation Biosciences (REVB) Stock Forecast & Price Target

27 Followers
See the Price Targets and Ratings of:

REVB Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Revelation
Biosciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

REVB Stock 12 Months Forecast

There Are No Analyst Ratings for REVB In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

REVB Financial Forecast

REVB Earnings Forecast

Next quarter’s earnings estimate for REVB is -$0.46 with a range of -$0.46 to -$0.45. The previous quarter’s EPS was -$0.42. REVB beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.67% of the time in the same period. In the last calendar year REVB has Underperformed its overall industry.
Next quarter’s earnings estimate for REVB is -$0.46 with a range of -$0.46 to -$0.45. The previous quarter’s EPS was -$0.42. REVB beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.67% of the time in the same period. In the last calendar year REVB has Underperformed its overall industry.
No data currently available

REVB Sales Forecast

Next quarter’s sales forecast for REVB is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. REVB beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.45% of the time in the same period. In the last calendar year REVB has Underperformed its overall industry.
Next quarter’s sales forecast for REVB is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. REVB beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.45% of the time in the same period. In the last calendar year REVB has Underperformed its overall industry.
No data currently available

REVB Analyst Recommendation Trends

REVB has not received any ratings in the last 3 months.
REVB has not received any ratings in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Roth MKM
$15.00
Buy
2084.36%
Upside
Reiterated
02/14/23
Roth MKM Maintains Buy on Revelation Biosciences, Raises Price Target to $15

Best Analysts Covering Revelation Biosciences

Which Analyst Should I Follow If I Want to Buy REVB and Sell After:
1 Month
Success Rate
0/4 ratings generated profit
0%
Average Return
-19.57%
reiterated a buy rating 10 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -19.57% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Success Rate
0/4 ratings generated profit
0%
Average Return
-46.10%
reiterated a buy rating 10 months ago
Copying Jonathan Aschoff's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -46.10% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Success Rate
0/4 ratings generated profit
0%
Average Return
-90.00%
reiterated a buy rating 10 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -90.00% per trade.
2 Years
Success Rate
0/4 ratings generated profit
0%
Average Return
-91.00%
reiterated a buy rating 10 months ago
Copying Jonathan Aschoff's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -91.00% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

REVB Stock Forecast FAQ

What is REVB’s average 12-month price target, according to analysts?
Currently, no data Available
What is REVB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for REVB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is REVB a Buy, Sell or Hold?
      Currently, no data Available
      What is Revelation Biosciences’s price target?
      Currently, no data Available
      What do analysts say about Revelation Biosciences?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of REVB?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis